Thomas Stephan
Stock Analyst at Stifel
(1.40)
# 3,577
Out of 5,180 analysts
60
Total ratings
32.43%
Success rate
-8.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Hold | $115 → $130 | $94.31 | +37.84% | 2 | Mar 9, 2026 | |
| OFIX Orthofix Medical | Maintains: Buy | $22 → $18 | $11.32 | +59.01% | 2 | Mar 9, 2026 | |
| ATEC Alphatec Holdings | Maintains: Buy | $24 → $20 | $11.00 | +81.82% | 3 | Mar 9, 2026 | |
| ALC Alcon | Maintains: Hold | $80 → $82 | $73.67 | +11.31% | 7 | Mar 9, 2026 | |
| STAA STAAR Surgical Company | Maintains: Hold | $19 → $18 | $18.34 | -1.85% | 12 | Mar 4, 2026 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $8 | $3.68 | +117.39% | 8 | Mar 2, 2026 | |
| GKOS Glaukos | Maintains: Buy | $115 → $160 | $105.01 | +52.37% | 10 | Jan 22, 2026 | |
| GMED Globus Medical | Reinstates: Hold | $64 | $83.51 | -23.36% | 1 | Oct 28, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $6.09 | +359.77% | 10 | Mar 19, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.26 | +17.96% | 3 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 | $0.99 | +102.02% | 2 | May 15, 2024 |
TransMedics Group
Mar 9, 2026
Maintains: Hold
Price Target: $115 → $130
Current: $94.31
Upside: +37.84%
Orthofix Medical
Mar 9, 2026
Maintains: Buy
Price Target: $22 → $18
Current: $11.32
Upside: +59.01%
Alphatec Holdings
Mar 9, 2026
Maintains: Buy
Price Target: $24 → $20
Current: $11.00
Upside: +81.82%
Alcon
Mar 9, 2026
Maintains: Hold
Price Target: $80 → $82
Current: $73.67
Upside: +11.31%
STAAR Surgical Company
Mar 4, 2026
Maintains: Hold
Price Target: $19 → $18
Current: $18.34
Upside: -1.85%
Sight Sciences
Mar 2, 2026
Maintains: Buy
Price Target: $6 → $8
Current: $3.68
Upside: +117.39%
Glaukos
Jan 22, 2026
Maintains: Buy
Price Target: $115 → $160
Current: $105.01
Upside: +52.37%
Globus Medical
Oct 28, 2025
Reinstates: Hold
Price Target: $64
Current: $83.51
Upside: -23.36%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $6.09
Upside: +359.77%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.26
Upside: +17.96%
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $0.99
Upside: +102.02%